Resources

Reports, fact sheets, and publications on HIV research, policy, and prevention.

A doctor in a white coat and stethoscope holds a clipboard and talks with a male patient in a bright medical exam room.
Policy and Advocacy

CDC Funding for Community-Based HIV Prevention Is Vital to End the U.S. Epidemic

New analyses by amfAR’s Public Policy Office show how community-based organizations are an essential to the U.S. HIV response and need funding.

September 29, 2026

Read More

Cover of report on PEPFAR disruptions and global impact analysis.
Policy and Advocacy

Taking the Pulse of PEPFAR

A new study by amfAR’s Public Policy Office documents how a withdrawal of U.S. funding for HIV services around the world is impacting the fight against AIDS

July 21, 2026

Read More

Cuts to the CDC’s Division of HIV Prevention Will Lead to Dramatic Rise in Infections, Deaths, and Costs
Policy and Advocacy

Cuts to the CDC’s Division of HIV Prevention Will Lead to Dramatic Rise in Infections, Deaths, and Costs

The U.S. Centers for Disease Control and Prevention (CDC) has led a concerted effort to curb the spread of HIV in the U.S. over the past 15 years. An amfAR analysis shows increased funding to the CDC’s Division of HIV Prevention has been associated with a nearly 20% reduction in new HIV infections across the […]

July 15, 2026

Read More

Domestic Funding Contributions to Health: Comparing Changes in Domestic Financing in PEPFAR and Non-PEPFAR Supported Countries

Domestic Funding Contributions to Health: Comparing Changes in Domestic Financing in PEPFAR and Non-PEPFAR Supported Countries

July 15, 2026

Read More

New Agreements for Funding Global HIV Program Miss the Mark 
Policy and Advocacy

New Agreements for Funding Global HIV Program Miss the Mark 

A new amfAR report analyzes how the new Global Health MOUs fail to establish metrics to measure their success Today, amfAR is releasing a report on the America First Global Health Strategy’s first set of seven publicly available Memoranda of Understanding (MOUs) with the countries of Ethiopia, Kenya, Liberia, Mozambique, Nigeria, Rwanda, and Uganda. The […]

April 7, 2026

Read More

HIV Prevention Snapshot: Lenacapavir
TREAT Asia

HIV Prevention Snapshot: Lenacapavir

January 14, 2026

Read More

Focus on Key Populations Remains Integral to the HIV Response
Policy and Advocacy

Focus on Key Populations Remains Integral to the HIV Response

New amfAR report affirms the importance of investing in tailored prevention services to decrease new HIV infections

December 1, 2025

Read More

HIV Prevention Snapshot: Long-Acting Cabotegravir (CAB-LA)
TREAT Asia

HIV Prevention Snapshot: Long-Acting Cabotegravir (CAB-LA)

November 24, 2025

Read More

Expanding HIV Prevention Options in the Asia-Pacific Region
Global Health

Expanding HIV Prevention Options in the Asia-Pacific Region

amfAR’s TREAT Asia program has created a guide to long-acting cabotegravir (CAB LA) for HIV prevention, an injectable form of PrEP.

November 24, 2025

Read More

The Future of Investment in Global Cervical Cancer Elimination: A Lifesaving Vision at Risk
Policy and Advocacy

The Future of Investment in Global Cervical Cancer Elimination: A Lifesaving Vision at Risk

November 17, 2025

Read More